Advanced Enzyme Technologies Reports Strong Q4 FY26 Growth

Advanced Enzyme Technologies announced its Q4 and full-year fiscal 2026 financial results. For the fourth quarter ended March 31, 2026, the company reported revenue of ₹218.7 crore, marking an 11.2% increase year-over-year. Net profit for the quarter jumped 20.5% to ₹61.8 crore.

Full-year results showed significant growth as well. Revenue for fiscal year 2026 reached ₹842.9 crore on a consolidated basis, a 15% increase compared to the previous year. Consolidated net profit for FY26 stood at ₹235.8 crore.

The company highlighted strong export growth as a key driver for its Q4 performance.

To provide investors with deeper insights into these results and the company's outlook for FY27, Advanced Enzyme Technologies has made the audio recording of its conference call available. The call, which took place on May 12, 2026, allowed management to discuss the audited financial figures and provide strategic commentary.

This recording offers shareholders direct access to management's detailed analysis of performance drivers, challenges, and future plans beyond the official financial statements. A transcript of the call is also expected to be released.

While the company focuses on growth, inherent sector risks such as fluctuations in raw material costs and currency exchange rates continue to be factors. Market competition, both domestically and globally, also presents ongoing challenges. Companies like Lumis Industries Ltd operate on a different scale within specialty enzymes, while global leaders such as Novozymes offer benchmarks for broader innovation and market penetration strategies.

Investors will be tracking management's commentary on key strategic insights for FY27, current market conditions, the competitive landscape, and any updates on new product development or market expansion initiatives.